• Citer

Belgian multicenter clinical study of alfuzosin, a selective alpha 1-blocker, in the treatment of benign prostatic hyperplasia. The Alfuzosin Belgian Group.

par Schulman, Claude ;De Sy, W.;Vandendris, Michel ;Tomas, Marc ;Santoni, J P
Référence Acta urologica Belgica, 62, 4, page (15-21)
Publication Publié, 1994-12

Article révisé par les pairs

• Détails
• Contenu

Titre:	Belgian multicenter clinical study of alfuzosin, a selective alpha 1-blocker, in the treatment of benign prostatic hyperplasia. The Alfuzosin Belgian Group.
Auteur:	Schulman, Claude; De Sy, W.; Vandendris, Michel; Tomas, Marc; Santoni, J P
Informations sur la publication:	Acta urologica Belgica, 62, 4, page (15-21)
Statut de publication:	Publié, 1994-12
Sujet CREF:	Néphrologie - urologie
Mots-clés:	alfuzosin
	alpha-1-adrenoceptor blocker
	benign prostatic hyperplasia
	Boyarsky score
	urinary flow measurement
MeSH keywords:	Adrenergic alpha-Antagonists -- therapeutic use
	Adult
	Aged
	Cross-Over Studies
	Double-Blind Method
	Humans
	Male
	Middle Aged
	Prostatic Hyperplasia -- drug therapy
	Quinazolines -- adverse effects -- therapeutic use
Note générale:	Clinical Trial
	Journal Article
	Multicenter Study
	Randomized Controlled Trial
Langue:	Anglais
Identificateurs:	urn:issn:0001-7183
	info:scp/0028603454
	info:pmid/7540794